Clinical trial
A Clinical Investigation of the Adjustable Continence Therapy (ACT) for Female Stress Urinary Incontinence Due to Intrinsic Sphincter Deficiency
NCT04248283 is registered in ClinicalTrials.gov with Uromedica as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Clinical Investigation of the Adjustable Continence Therapy (ACT) for Female Stress Urinary Incontinence Due to Intrinsic Sphincter Deficiency
- Lead sponsor
- Uromedica
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- January 26, 2021
- Completion date
- May 31, 2032
- Enrollment
- 167 (estimated)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.
urinary incontinence, urinary incontinence,stress